LATE BREAKING: New Phase III Data for Cladribine to be Presented at AAN

CLARITY (CLAdRIbine tablets Treating MS OrallY) Study Data to be Presented as Late-Breaking Oral Presentation By: PR Newswire Mar. 30, 2009 08:01 AM // GENEVA, Switzerland, March [...]

• Caroline says: AAN has accepted a late-breaking oral presentation on Merck/Serono's oral cladribine Phase III results. Most medical conferences decide what abstracts and subject matter they're approving months before the actual congress. So, this means that the investigator of this study has some potentially new and riveting findings for us. The abstract is embargoed until AAN, but this could be big news for all you oral fans...
   

• Breast Feeding Works Miracles for Both Baby and Mother with MS

  AAN 2009: Breast-Feeding May Reduce Multiple Sclerosis Relapses Allison Gandey February 23, 2009 — Women who have multiple sclerosis (MS) may reduce their risk for relapse after [...]

  • Caroline says: These findings were released in advance of AAN's annual meeting this April. These are just fascinating. For the last decade, women with MS have often been encouraged to restart their MS meds soon after child birth to truncate or avoid relapse. Many avoid breast feeding their babies to do so. This article suggests that women actually may be better off breast feeding their babies because it delays their menstrual cycle a bit longer (estrogen!) More studies are needed, though this is food for thought if you are pregnant or planning pups sometime in the future.
     
  
  
  Next Entries »